Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.

BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J
Format:	Journal article
Język:	English
Wydane:	BioMed Central 2011

Podobne zapisy

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
od: Lindegardh Niklas, i wsp.
Wydane: (2011-07-01)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
od: Jamsen, K, i wsp.
Wydane: (2012)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
od: Jamsen Kris M, i wsp.
Wydane: (2012-07-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
od: Luxemburger, C, i wsp.
Wydane: (1995)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
od: Mcgready, R, i wsp.
Wydane: (2006)

Towards optimal design of anti-malarial pharmacokinetic studies.
od: Simpson, J, i wsp.
Wydane: (2009)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
od: Adam, I, i wsp.
Wydane: (2012)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
od: Kloprogge, F, i wsp.
Wydane: (2013)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
od: Tarning, J, i wsp.
Wydane: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
od: Adam, I, i wsp.
Wydane: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
od: Rijken, M, i wsp.
Wydane: (2011)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
od: Nosten, F
Wydane: (2010)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
od: Tarning, J, i wsp.
Wydane: (2009)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
od: Hoglund, R, i wsp.
Wydane: (2012)

Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.
od: Price, R, i wsp.
Wydane: (1998)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Uganda
od: Tarning Joel, i wsp.
Wydane: (2012-08-01)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
od: Mcgready, R, i wsp.
Wydane: (2012)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
od: Kloprogge, F, i wsp.
Wydane: (2014)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
od: Mcgready, R, i wsp.
Wydane: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
od: McGready, R, i wsp.
Wydane: (2009)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
od: Tarning, J, i wsp.
Wydane: (2007)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated <it>Plasmodium falciparum </it>malaria
od: Quezada Wilmer, i wsp.
Wydane: (2009-04-01)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
od: Valea, I, i wsp.
Wydane: (2014)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
od: Bethell, D, i wsp.
Wydane: (1997)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
od: Price, R, i wsp.
Wydane: (1999)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
od: Birgersson, S, i wsp.
Wydane: (2019)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2014)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
od: Hoglund Richard M, i wsp.
Wydane: (2012-11-01)

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
od: Newton, P, i wsp.
Wydane: (2006)

Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
od: Monia Guidi, i wsp.
Wydane: (2019-04-01)

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
od: van Vugt, M, i wsp.
Wydane: (2002)

Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin
od: Michelle V. D. Ferreira, i wsp.
Wydane: (2018-07-01)

Towards optimal design of anti-malarial pharmacokinetic studies
od: White Nicholas J, i wsp.
Wydane: (2009-08-01)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
od: Kloprogge, F, i wsp.
Wydane: (2015)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
od: Ashley, E, i wsp.
Wydane: (2006)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
od: Oméga Raobela, i wsp.
Wydane: (2018-08-01)